Therapeutic uses of stem cells

Fundamentals of the Stem Cell Debate: The Scientific, Religious, Ethical,and Political Issues

Volumn , Issue , 2007, Pages 37-61

  Schwartz, Philip H ^a,b   Bryant, Peter J ^c  

^a Children's Hospital of Orange County Research Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCI Department of Developmental and Cell Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887720835     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (92)

1. Aboody, K. S., A. Brown, N. G. Rainov, K. A. Bower, S. Liu, W. Yang, J. E. Small, U. Herrlinger, V. Ourednik, P. M. Black, X. O. Breakefield, and E.Y. Snyder. 2000. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc. Natl. Acad. Sci. U.S.A. 97:12846-51.
2. Allegrucci, C., C. Denning, H. Priddle, and L. Young. 2004. Stem-cell consequences of embryo epigenetic defects. Lancet 364:206-8.
3. Alzheimer's Association. 2005. Fact sheet. www.alz.org/documents/national/FSAlzheimerstats.pdf. Accessed May 3, 2007.
4. Amado, L. C., A. P. Saliaris, K. H. Schuleri, M. St. John, J. S. Xie, S. Cattaneo, D. J. Durand, T. Fitton, J. Q. Kuang, G. Stewart, S. Lehrke, W.W. Baumgartner, B. J. Martin, A.W. Heldman, and J. M. Hare. 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 102:11474-79.
5. American Diabetes Association. 2007. All about diabetes. 222.diabetes.org/about-diabetes.jsp. Accessed May 3, 2007.
6. American Heart Association. 2007. Heart disease and stroke statistics-2007 update. http://circ/ ahajournals.org/cgi/content/full/115/5/e69/TBL1179728. Accessed May 3, 2007.
7. American Parkinson Disease Association. 2003. American Parkinson Disease Association Inc. www.apdaparkinson.org/user/index.asp. Accessed May 3, 2007.
8. Anversa, P., A. Leri, J. Kajstura, and B. Nadal-Ginard. 2002. Myocyte growth and cardiac repair. J. Mol. Cell Cardiol. 34:91-105.
9. Arnhold, S., H. Klein, I. Semkova, K. Addicks, and U. Schraermeyer. 2004. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest. Ophthalmol. Vis. Sci. 45:4251-55.
10. Arnhold, S., I. Semkova, C. Andressen, D. Lenartz, G. Meissner, V. Sturm, S. Kochanek, K. Addicks, and U. Schraermeyer. 2004. Iris pigment epithelial cells: A possible cell source for the future treatment of neurodegenerative diseases. Exp. Neurol. 187:410-17.
11. Baird, S. M. 2003. Hematopoietic stem cells in leukemia and lymphoma. In: S. Sell, ed. Stem Cells Handbook, 163-76. Totowa, NJ: Humana Press.
12. Beatty, P.G. 1997. National Heart, Lung, and Blood Institute (NHLBI) workshop on the importance of minor histocompatibility antigens in marrow transplantation. Sept. 16-17, 1996; Bethesda, MD. Exp. Hematol. 25:548-58.
13. Beltrami, A. P., L. Barlucchi, D. Torella, M. Baker, F. Limana, S. Chimenti, H. Kasahara, M. Rota, E. Musso, K. Urbanek, A. Leri, J. Kajstura, B. Nadal- Ginard, and P. Anversa. 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-76.
14. Berna, G., T. Leon-Quinto, R. Ensenat-Waser, E. Montanya, F. Martin, and B. Soria. 2001. Stem cells and diabetes. Biomed. Pharmacother. 55:206-12.
15. Beyth, S., Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, H. Aslan, E. Galun, and J. Rachmilewitz. 2005. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-19.
16. Brown, A. B., W. Yang, N. O. Schmidt, R. Carroll, K. K. Leishear, N. G. Rainov, P. M. Black, X. O. Breakefield, and K. S. Aboody. 2003. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum. Gene Ther. 14:1777-85.
17. Brustle, O., K. N. Jones, R. D. Learish, K. Karram, K. Choudhary, O. D. Wiestler, I. D. Duncan, and R. D. McKay. 1999. Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science 285:754-56.
18. Brustle, O., A. C. Spiro, K. Karram, K. Choudhary, S. Okabe, and R. D. McKay. 1997. In vitro-generated neural precursors participate in mammalian brain development. Proc. Natl. Acad. Sci. U.S.A. 94:14809-14.
19. Burke, R. E. 2004. Ontogenic cell death in the nigrostriatal system. Cell Tissue Res. 318:63-72.
20. Christopher and Dana Reeve Foundation. 2007. SCI facts. www.christopherreeve.org/site/c.geIMLPOpGjF/b.1402847/k.EE60/SCI_Facts.htm. Accessed May 3, 2007.
21. Cottler-Fox, M. H., T. Lapidot, I. Petit, O. Kollet, J. F. DiPersio, D. Link, and S. Devine. 2003. Stem cell mobilization. Hematology (Am. Soc. Hematol. Educ. Program) 419-37.
22. Davies, J. H., B. A. Evans, M. E. Jenney, and J.W. Gregory. 2005. Skeletal morbidity in childhood acute lymphoblastic leukaemia. Clin. Endocrinol. (Oxf.) 63:1-9.
23. De Rycke, M., I. Liebaers, and A. Van Steirteghem. 2002. Epigenetic risks related to assisted reproductive technologies: Risk analysis and epigenetic inheritance. Hum. Reprod. 17:2487-94.
24. Dennis, J. E., and A. I. Caplan. 2003. Bone marrow mesenchymal stem cells. In: S. Sell, ed. Stem Cells Handbook, 107-18. Totowa, NJ: Humana Press.
25. Dickenson, D. 2004. The threatened trade in human ova. Nat. Rev. Genet. 5:167.
26. Drucker-Colin, R., and L. Verdugo-Diaz. 2004. Cell transplantation for Parkinson's disease: Present status. Cell Mol. Neurobiol. 24:301-16.
27. Ehtesham, M., P. Kabos, M. A. Gutierrez, N. H. Chung, T. S. Griffith, K. L. Black, and J. S. Yu. 2002. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 62:7170-74.
28. Eto, Y., J. S. Shen, X. L. Meng, and T. Ohashi. 2004. Treatment of lysosomal storage disorders: Cell therapy and gene therapy. J. Inherit. Metab. Dis. 27:411-15.
29. Fairchild, P. J., S. Cartland, K. F. Nolan, and H. Waldmann. 2004. Embryonic stem cells and the challenge of transplantation tolerance. Trends Immunol. 25:465-70.
30. Fairchild, P. J., K. F. Nolan, S. Cartland, and H. Waldmann. 2005. Embryonic stem cells: A novel source of dendritic cells for clinical applications. Int. Immunopharmacol. 5:13-21.
31. Furlan, R., S. Pluchino, and G. Martino. 2003. The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system. Curr. Opin. Neurol. 16:385-92.
32. Goldman, J. M., and M. M. Horowitz. 2002. The international bone marrow transplant registry. Int. J. Hematol. 76, suppl. 1, 393-97.
33. Grilley, B. J., and A. P. Gee. 2003. Gene transfer: Regulatory issues and their impact on the clinical investigator and the good manufacturing production facility. Cytotherapy 5:197-207.
34. Grondin, R., Z. Zhang, Y. Ai, D. M. Gash, and G. A. Gerhardt. 2003. Intracranial delivery of proteins and peptides as a therapy for neurodegenerative diseases. Prog. Drug Res. 61:101-23.
35. Heng, B. C., T. Cao, H. K. Haider, D. Z. Wang, E. K. Sim, and S. C. Ng. 2004. An overview and synopsis of techniques for directing stem cell differentiation in vitro. Cell Tissue Res. 315:291-303.
36. Imitola, J., K. Raddassi, K. I. Park, F. J. Mueller, M. Nieto, Y. D. Teng, D. Frenkel, J. Li, R. L. Sidman, C. A. Walsh, E.Y. Snyder, and S. J. Khoury. 2004. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. U.S.A. 101:18117-22.
37. Keirstead, H. S., G. Nistor, G. Bernal, M. Totoiu, F. Cloutier, K. Sharp, and O. Steward. 2005. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25:4694-4705.
38. Kelley, M.W., J. K. Turner, and T. A. Reh. 1995. Regulation of proliferation and photoreceptor differentiation in fetal human retinal cell cultures. Invest. Ophthalmol. Vis. Sci. 36: 1280-89.
39. Kim, D.W. 2004. Efficient induction of dopaminergic neurons from embryonic stem cells for application to Parkinson's disease. Yonsei Med. J. 45, suppl., 23-27.
40. Klassen, H., B. Ziaeian, I. I. Kirov, M. J. Young, and P. H. Schwartz. 2004. Isolation of retinal progenitor cells from post-mortem human tissue and comparison with autologous brain progenitors. J. Neurosci. Res. 77:334-43.
41. Klimanskaya, I., Y. Chung, L. Meisner, J. Johnson, M. D. West, and R. Lanza. 2005. Human embryonic stem cells derived without feeder cells. Lancet 365:1636-41.
42. Koc, O. N., J. Day, M. Nieder, S. L. Gerson, H. M. Lazarus, and W. Krivit. 2002. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30:215-22.
43. Lanza, R., M. A. Moore, T. Wakayama, A. C. Perry, J. H. Shieh, J. Hendrikx, A. Leri, S. Chimenti, A. Monsen, D. Nurzynska, M. D. West, J. Kajstura, and P. Anversa. 2004. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circ. Res. 94:820-27.
44. Lapidot, T., and I. Petit. 2002. Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30: 973-81.
45. Lechner, A., and J. F. Habener. 2003. Stem/progenitor cells derived from adult tissues: Potential for the treatment of diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 284:E259-66.
46. Lewis, I. D. 2002. Clinical and experimental uses of umbilical cord blood. Intern. Med. J. 32:601-9.
47. Li, L., M. L. Baroja, A. Majumdar, K. Chadwick, A. Rouleau, L. Gallacher, I. Ferber, J. Lebkowski, T. Martin, J. Madrenas, and M. Bhatia, M. 2004. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22:448-56.
48. Liu, S., Y. Qu, T. J. Stewart, M. J. Howard, S. Chakrabortty, T. F. Holekamp, and, J.W. McDonald. 2000. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc. Natl. Acad. Sci. U.S.A. 97:6126-31.
49. Lu, P., L. L. Jones, E.Y. Snyder, and M. H. Tuszynski. 2003. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 181:115-29.
50. Magnitsky, S., D. J. Watson, R. M. Walton, S. Pickup, J.W. Bulte, J. H. Wolfe, and H. Poptani. 2005. In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain. Neuroimage 26:744-54.
51. Magnus, D., and M. K. Cho. 2005. Ethics: Issues in oocyte donation for stem cell research. Science 308:1747-48.
52. Malatack, J. J., D. M. Consolini, and E. Bayever. 2003. The status of hematopoietic stem cell transplantation in lysosomal storage disease. Pediatr. Neurol. 29:391-403.
53. Martin, M. J., A. Muotri, F. Gage, and A. Varki. 2005. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11:228-32.
54. Mathur, A., and J. F. Martin. 2004. Stem cells and repair of the heart. Lancet 364:183-92.
55. McDonald, J.W., X. Z. Liu, Y. Qu, S. Liu, S. K. Mickey, D. Turetsky, D. I. Gottlieb, and, D.W. Choi. 1999. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5:1410-12.
56. Miyamoto, M. 2001. Current progress and perspectives in cell therapy for diabetes mellitus. Hum. Cell 14:293-300.
57. Nash, R. A., J. D. Bowen, P. A. McSweeney, S. Z. Pavletic, K. R. Maravilla, M. S. Park, J. Storek, K. M. Sullivan, J. Al Omaishi, J. R. Corboy, J. DiPersio, G. E. Georges, T. A. Gooley, L. A. Holmberg, C. F. LeMaistre, K. Ryan, H. Openshaw, J. Sunderhaus, R. Storb, J. Zunt, and G. H. Kraft. 2003. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 102:2364-72.
58. National Cancer Institute. 2006. Estimated cancer prevalence counts: Who are our cancer survivors in the US? http://cancercontrol.cancer.gov/ocs/prevalence. Accessed May 3, 2007.
59. National Institute of Allergy and Infectious Diseases. 2005. Progress in autoimmune diseases research. www.niaid.nih.gov/publications/pdf/ADCCFinal.pdf. Accessed May 3, 2007.
60. National Institute of Arthritis and Musculoskeletal and Skin Diseases. 2007. Bone health and osteoporosis: A surgeon general's report. What is bone disease? www.surgeongeneral.gov/library/bonehealth/factsheet1.html. Accessed May 3, 2007.
61. Niemitz, E. L., and A. P. Feinberg. 2004. Epigenetics and assisted reproductive technology: A call for investigation. Am. J. Hum. Genet. 74:599-609.
62. Nistor, G. I., M. O. Totoiu, N. Haque, M. K. Carpenter, and H. S. Keirstead. 2005. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49:385-96.
63. Nunes, M. C., N. S. Roy, H. M. Keyoung, R. R. Goodman, G. McKhann, L. Jiang, J. Kang, M. Nedergaard, and S. A. Goldman. 2003. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 9:439-47.
64. Ostenfeld, T., and C. N. Svendsen. 2003. Recent advances in stem cell neurobiology. Adv. Tech. Stand. Neurosurg. 28:3-89.
65. Pluchino, S., R. Furlan, and G. Martino. 2004. Cell-based remyelinating therapies in multiple sclerosis: Evidence from experimental studies. Curr. Opin. Neurol. 17:247-55.
66. Pluchino, S., A. Quattrini, E. Brambilla, A. Gritti, G. Salani, G. Dina, R. Galli, U. Del Carro, S. Amadio, A. Bergami, R. Furlan, G. Comi, A. L. Vescovi, and G. Martino. 2003. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422:688-94.
67. Pollack, A. 2004. Many see hope in Parkinson's drug pulled from testing. New York Times, Nov. 26.
68. Priddle, H., D. R. Jones, P.W. Burridge, and R. Patient. 2005. Hematopoiesis from human embryonic stem cells: Overcoming the immune barrier in stem cell therapies. Stem Cells 24:815-24.
69. QuickOverview.com. 2007. John Edwards. www.quickoverview.com/election2008/john-edwardsoverview.html. Accessed May 3, 2007.
70. Rianthavorn, P., R. B. Ettenger, M. Malekzadeh, J. L. Marik, and M. Struber. 2004. Noncompliance with immunosuppressive medications in pediatric and adolescent patients receiving solid-organ transplants. Transplantation 77:778-82.
71. Riaz, S. S., S. Theofilopoulos, E. Jauniaux, G. M. Stern, and H. F. Bradford. 2004. The differentiation potential of human foetal neuronal progenitor cells in vitro. Brain Res. Dev. Brain Res. 153:39-51.
72. Rice, C. M., C. A. Halfpenny, and N. J. Scolding. 2003. Stem cells for the treatment of neurological disease. Transfus. Med. 13:351-61.
73. Ringden, O., M. Schaffer, B. K. Le, U. Persson, D. Hauzenberger, M. R. Abedi, O. Olerup, P. Ljungman, and M. Remberger. 2004. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers? Biol. Blood Marrow Transplant. 10:128-34.
74. Roitberg, B., K. Urbaniak, and M. Emborg. 2004. Cell transplantation for Parkinson's disease. Neurol. Res. 26: 355-62.
75. Rubanyi, G. M. 2001. The future of human gene therapy. Mol. Aspects Med. 22:113-42.
76. Schieve, L. A., S. A. Rasmussen, G. M. Buck, D. E. Schendel, M. A. Reynolds, and V. C. Wright. 2004. Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet. Gynecol. 103:1154-63.
77. Schwartz, P.H., P. J. Bryant, T. J. Fuja, H. Su, D. K. O'Dowd, and H. Klassen. 2003. Isolation and characterization of neural progenitor cells from postmortem human cortex. J. Neurosci. Res. 74:838-51.
78. Shatos, M., K. Mizumoto, H. Mizumoto, Y. Kurimoto, H. Klassen, and M. Young. 2001. Multipotent stem cells from the brain and retina of green mice. J. Regen. Med. 2:13-15.
79. Shihabuddin, L. S., S. Numan, M. R. Huff, J. C. Dodge, J. Clarke, S. L. Macauley, W. Yang, T.V. Taksir, G. Parsons, M. A. Passini, F. H. Gage, and G. R. Stewart. 2004. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology. J. Neurosci. 24:10642-51.
80. Simpson, E. 1998. Minor transplantation antigens: Animal models for human hostversus- graft, graft-versus-host, and graft-versus-leukemia reactions. Transplantation 65:611-16.
81. Somia, N., and I. M. Verma. 2000. Gene therapy: Trials and tribulations. Nat. Rev. Genet. 1:91-99.
82. Stojkovic, M., P. Stojkovic, C. Leary, V. J. Hall, L. Armstrong, M. Herbert, M. Nesbitt, M. Lako, and A. Murdoch. 2005. Derivation of a human blastocyst after heterologous nuclear transfer to donated oocytes. Reprod. Biomed. Online 11:226-31.
83. Sykes, M., and B. Nikolic. 2005. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435:620-27.
84. Takahashi, M., T. D. Palmer, J. Takahashi, and F. H. Gage. 1998. Widespread integration and survival of adult-derived neural progenitor cells in the developing optic retina. Mol. Cell Neurosci. 12:340-48.
85. Van Steirteghem, A., M. Bonduelle, P. Devroey, and I. Liebaers. 2002. Follow-up of children born after ICSI. Hum. Reprod. Update 8:111-16.
86. Verlinsky, Y., S. Rechitsky, T. Sharapova, R. Morris, M. Taranissi, and A. Kuliev. 2004. Preimplantation HLA testing. JAMA 291:2079-85.
87. Vescovi, A. L., E. A. Parati, A. Gritti, P. Poulin, M. Ferrario, E. Wanke, P. Frolichsthal-Schoeller, L. Cova, M. Arcellana-Panlilio, A. Colombo, and R. Galli. 1999. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp. Neurol. 156:71-83.
88. Wei, J., S. Blum, M. Unger, G. Jarmy, M. Lamparter, A. Geishauser, G. A. Vlastos, G. Chan, K. D. Fischer, D. Rattat, K. M. Debatin, A. K. Hatzopoulos, and C. Beltinger. 2004. Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 5:477-88.
89. Yang, P., M. J. Seiler, R. B. Aramant, and S. R. Whittemore. 2002. In vitro isolation and expansion of human retinal progenitor cells. Exp. Neurol. 177:326-31.
90. Yip, S., K. S. Aboody, M. Burns, J. Imitola, J. A. Boockvar, J. Allport, K. I. Park, Y. D. Teng, M. Lachyankar, T. McIntosh, D. M. O'Rourke, S. Khoury, R. Weissleder, P. M. Black, W. Weiss, and E.Y. Snyder. 2003. Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J. 9:189-204.
91. Yoon, Y. S., A. Wecker, L. Heyd, J. S. Park, T. Tkebuchava, K. Kusano, A. Hanley, H. Scadova, G. Qin, D. H. Cha, K. L. Johnson, R. Aikawa, T. Asahara, and D.W. Losordo. 2005. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115:326-38.
92. Young, M. J., J. Ray, S. J. Whiteley, H. Klassen, and F. H. Gage. 2000. Neuronal differentiation and morphological integration of hippocampal progenitor cells transplanted to the retina of immature and mature dystrophic rats. Mol. Cell Neurosci. 16:197-205.